TrendRadars > News > SII Seeks from DCGI Market Authorisation for India’s First QHPV Vaccine Against Cervical Cancer
SII Seeks from DCGI Market Authorisation for India’s First QHPV Vaccine Against Cervical Cancer
SII Seeks from DCGI Market Authorisation for India's First QHPV Vaccine Against Cervical Cancer,The Pune-based firm has applied for market authorisation after completing the phase 2/3 clinical trial with support of the Department of Biotechnology to ensure its early availability in the country, they said

SII Seeks from DCGI Market Authorisation for India’s First QHPV Vaccine Against Cervical Cancer

The Pune-based firm has applied for market authorisation after completing the phase 2/3 clinical trial with support of the Department of Biotechnology to ensure its early availability in the country, they said